Glucose metabolism in small subcortical structures in Parkinson's disease

Acta Neurologica Scandinavica

Volumn 125, Issue 5, 2012, Pages 303-310

  Borghammer, Per ^a   Hansen, Søren B ^a   Eggers, Carsten ^b   Chakravarty, Mallar ^c   Vang, Kim ^a   Aanerud, Joel ^a   Hilker, Rüdiger ^d   Heiss, Wolf Dieter ^e   Rodell, Anders ^a   Munk, Ole L ^a   Keator, David ^f   Gjedde, Albert ^a,g  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d GOETHE UNIVERSITY   (Germany)

^e MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glucose; Metabolism; Normalization; Parkinson's disease; Positron emission tomography

Indexed keywords

DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; HYPERMETABOLISM; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; THALAMUS NUCLEUS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

AGED; BRAIN; BRAIN DISEASES, METABOLIC; CASE-CONTROL STUDIES; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84859430643     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01556.x     Document Type: Article

References (29)

1. Palombo E, Porrino LJ, Bankiewicz KS, Crane AM, Sokoloff L, Kopin IJ. Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J Neurosci 1990;10:860-9.
2. Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the primate. Life Sci 1987;40:1657-64.
3. Valk PE, Bailey DL, Townsend DW, Maisey MN. Positron Emission Tomography - Basic Science and Clinical Applications. London: Springer, 2003; 884.
4. Eggers C, Hilker R, Burghaus L, Schumacher B, Heiss WD. High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease. J Neurol Sci 2009;276:27-30.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
6. Heiss WD, Habedank B, Klein JCet al. Metabolic rates in small brain nuclei determined by high-resolution PET. J Nucl Med 2004;45:1811-5.
7. Liu X, Comtat C, Michel C, Kinahan P, Defrise M, Townsend D. Comparison of 3-D reconstruction with 3D-OSEM and with FORE+OSEM for PET. IEEE Trans Med Imaging 2001;20:804-14.
8. Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RJ. Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 1984;4:35-40.
9. Borghammer P, Chakravarty M, Jonsdottir KYet al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct 2010;214:303-17.
10. Chakravarty MM, Bertrand G, Hodge CP, Sadikot AF, Collins DL. The creation of a brain atlas for image guided neurosurgery using serial histological data. Neuroimage 2006;30:359-76.
11. Chakravarty MM, Sadikot AF, Germann J, Bertrand G, Collins DL. Towards a validation of atlas warping techniques. Med Image Anal 2008;12:713-26.
12. Chakravarty MM, Sadikot AF, Germann J, Hellier P, Bertrand G, Collins DL. Comparison of piece-wise linear, linear, and nonlinear atlas-to-patient warping techniques: analysis of the labeling of subcortical nuclei for functional neurosurgical applications. Hum Brain Mapp 2009;30:3574-95.
13. Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A. Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization. Neuroimage 2009;47:1514-21.
14. Borghammer P, Cumming P, Aanerud J, Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Neuroimage 2009;45:249-57.
15. Yakushev I, Hammers A, Fellgiebel Aet al.SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009;44:43-50.
16. Worsley KJ, Liao CH, Aston Jet al.A general statistical analysis for fMRI data. Neuroimage 2002;15:1-15.
17. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, And Evans AC. A Unified Statistical Approach for Determining Significant Signals in Images of Cerebral Activation. Hum Brain Mapp 1996;4:58-73.
18. Alexander GE, Crutcher MD, Delong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-46.
19. Obeso JA, Marin C, Rodriguez-Oroz Cet al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann Neurol 2008;64(Suppl 2):S30-46.
20. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-9.
21. Eidelberg D, Moeller JR, Dhawan Vet al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801.
22. Nagano-Saito A, Kato T, Arahata Yet al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 2004;22:553-61.
23. Asanuma K, Tang C, Ma Yet al. Network modulation in the treatment of Parkinson's disease. Brain 2006;129:2667-78.
24. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 2007;27:597-605.
25. Melzer TR, Watts R, Macaskill MRet al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 2011;134(Pt 3):845-55.
26. Kalpouzos G, Chetelat G, Baron JCet al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 2009;30:112-24.
27. Habeck CG. Basics of multivariate analysis in neuroimaging data. J Vis Exp 2010;41:pii:1988.
28. Borghammer P, Jonsdottir KY, Cumming Pet al. Normalization in PET group comparison studies--the importance of a valid reference region. Neuroimage 2008;40:529-40.
29. Borghammer P, Aanerud J, Gjedde A. Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 2009;46:981-8.